A Phase 2 trial of a four-drug regimen including Sarclisa Escena (isatuximab-irfc) showed promising treatment responses in people ages…
Articles by Marisa Horak, MS
Early treatment with Jakafi (ruxolitinib) is no better than older therapies at inducing a complete response in those with…
The European Commission has cleared Tecvayli (teclistamab-cqyv) as a monotherapy, meaning it can be given on its own, for…
Changes in blood levels of an enzyme called lactate dehydrogenase (LDH) may offer clues about disease activity in glioblastoma, an…
The International Myeloma Foundation has started a first-of-its-kind national clinical research network aiming to expand access to clinical trials…
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the investigational therapy onvansertib as a potential…
An approved treatment regimen using the oral therapy Zenbexus (iberdomide) can reduce the risk of disease progression among people…
An experimental therapy containing a specific ratio of two naturally occurring pancreatic enzymes may be able to reduce the growth…
An arm of the European Medicines Agency (EMA) — which reviews clinical trial data for drugs under regulatory review in…
A first-in-human clinical trial testing Orum Therapeutics‘ infusion therapy ORM-1153 in people with hard-to-treat acute myeloid leukemia (AML), a form…